Literature DB >> 8208238

Surveillance for smoking-attributable mortality and years of potential life lost, by state--United States, 1990.

D E Nelson, R S Kirkendall, R L Lawton, J H Chrismon, R K Merritt, D A Arday, G A Giovino.   

Abstract

PROBLEM/CONDITION: Mortality and years of potential life lost attributable to cigarette smoking. REPORTING PERIOD COVERED: 1990. DESCRIPTION OF SYSTEM: Mortality and years of potential life lost were estimated for each state by using the Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) software. These estimates were based on attributable risk formulas for smoking-related causes of death. Estimates of smoking prevalence were obtained from the Behavioral Risk Factor Surveillance System and the U.S. Bureau of the Census, and mortality data were obtained from CDC.
RESULTS: The median estimate for the number of smoking-attributable deaths among states was 5,619 (range: 402 [Alaska] to 42,574 [California]). Within each state, the number of smoking-attributable deaths among males was approximately twice as high as among females. Utah had the lowest mortality rate (218.0 per 100,000 population) and the lowest percentage of all deaths attributable to cigarette smoking (13.4%). Nevada had the highest mortality rate (478.1 per 100,000 population) and the highest percentage of deaths from smoking (24.0%). The number of years of potential life lost ranged from 6,720 (Alaska) to 498,297 (California).
INTERPRETATION: The number of deaths attributable to cigarette smoking in 1990 remained high. Efforts are needed to control tobacco use in all states. ACTIONS TAKEN: SAMMEC data are used in many states to assist policymakers in strengthening tobacco control efforts.

Entities:  

Mesh:

Year:  1994        PMID: 8208238

Source DB:  PubMed          Journal:  MMWR CDC Surveill Summ


  13 in total

1.  Estimating the health consequences of replacing cigarettes with nicotine inhalers.

Authors:  W Sumner
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

2.  Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model.

Authors:  D B Abrams; C T Orleans; R S Niaura; M G Goldstein; J O Prochaska; W Velicer
Journal:  Ann Behav Med       Date:  1996

3.  Comparing tobacco use among incoming recruits and military personnel on active duty in the United States.

Authors:  M C Chisick; F R Poindexter; A K York
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

4.  Smoking cessation and the nicotine patch: much more to be done.

Authors:  S E Kimmel; N Benowitz
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

5.  Accessibility of cigarettes to minors in suburban Cook County, Illinois.

Authors:  S R McDermott; K L Scott; M P Frintner
Journal:  J Community Health       Date:  1998-04

6.  State smoking prevalence estimates: a comparison of the Behavioral Risk Factor Surveillance System and current population surveys.

Authors:  D R Arday; S L Tomar; D E Nelson; R K Merritt; M W Schooley; P Mowery
Journal:  Am J Public Health       Date:  1997-10       Impact factor: 9.308

7.  Tobacco carcinogen NNK transporter MRP2 regulates CFTR function in lung epithelia: implications for lung cancer.

Authors:  Chunying Li; John D Schuetz; Anjaparavanda P Naren
Journal:  Cancer Lett       Date:  2010-01-20       Impact factor: 8.679

8.  Smoking-attributable cancer mortality in California, 1979-2005.

Authors:  David W Cowling; Juan Yang
Journal:  Tob Control       Date:  2010-04       Impact factor: 7.552

9.  Daily assessment of arterial distensibility in a pediatric population before and after smoking cessation.

Authors:  Pier Paolo Bassareo; Vassilios Fanos; Antonio Crisafulli; Giuseppe Mercuro
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

Review 10.  Methodologies used to estimate tobacco-attributable mortality: a review.

Authors:  Mónica Pérez-Ríos; Agustín Montes
Journal:  BMC Public Health       Date:  2008-01-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.